标普生物科技LOF(161127)
动态评分: 4.62分
投资组合

报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
2019-12-31 | ANIK | 阿尼卡医疗 | 29.66 | 0.39% |
2019-12-31 | EGRX | Eagle制药 | 29.63 | 0.39% |
2019-12-31 | VKTX | Viking Therapeutics Inc | 29.85 | 0.39% |
2019-12-31 | AMAG | AMAG Pharmaceutical Inc | 28.53 | 0.38% |
2019-12-31 | ATNX | Athenex Inc | 28.1 | 0.37% |
2019-12-31 | VNDA | Vanda Pharmaceuticals Inc | 26.5 | 0.35% |
2019-12-31 | MNTA | Momenta Pharmaceuticals Inc | 26.17 | 0.34% |
2019-12-31 | OPK | OPKO健康 | 23.2 | 0.31% |
2019-12-31 | VCEL | Vericel Corp | 23.45 | 0.31% |
2019-12-31 | ACHN | 爱克莱恩 | 22.19 | 0.29% |
2019-12-31 | KOD | Kodiak Sciences Inc | 21.93 | 0.29% |
2019-12-31 | PRNB | Principia Biopharma Inc | 22.36 | 0.29% |
2019-12-31 | STML | Stemline Therapeutics Inc | 22.11 | 0.29% |
2019-12-31 | KRYS | Krystal Biotech Inc | 21.21 | 0.28% |
2019-12-31 | BBIO | BridgeBio Pharma Inc | 20.61 | 0.27% |
2019-12-31 | GOSS | Gossamer Bio Inc | 20.4 | 0.27% |
2019-12-31 | NTLA | Intellia Therapeutics Inc | 20.4 | 0.27% |
2019-12-31 | TVTX | Travere Therapeutics Inc | 20.15 | 0.27% |
2019-12-31 | DRNA | Dicerna Pharmaceuticals Inc | 19.76 | 0.26% |
2019-12-31 | IMGN | ImmunoGen Inc | 19.4 | 0.26% |
公告&资料
